The global carboplatin injection market is expected to grow at a significant CAGR during the forecast period (2021-2027). Carboplatin is a chemotherapeutic drug that is offered under various brand names, including Paraplatin. It is used to treat a variety of cancers including ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma. It is administered through a venous injection. The increasing prevalence of cancer is contributing to the growth of the market. For instance, as per Cancer.gov, in the US, head and neck cancers account for roughly 4% of all cancers. Men are more than twice as likely as women affected with these cancers. Cancers of the head and neck are also diagnosed more frequently in those over 50 than in younger people. In 2021, more than 68,000 men and women in the US were diagnosed with head and neck cancers. The majority of people were diagnosed with mouth, throat, or voice box cancer.
To Request a Sample of our Report on Global Carboplatin Injection Market: https://www.omrglobal.com/request-sample/carboplatin-injection-market
Further, according to Cancer.org, ovarian cancer is the sixth leading cause of cancer mortality in women, killing more women than any other cancer of the female reproductive system. A woman’s lifetime risk of developing ovarian cancer is roughly 1 in 78. Her chances of dying from ovarian cancer are roughly 1 in 108 in her lifetime. This cancer primarily affects women in their 40 or 50s. About half of all women diagnosed with ovarian cancer are above the age of 63. White women are more likely to have it than African-American women. However, over the last 20 years, the number of women diagnosed with ovarian cancer has steadily decreased. Carboplatin is utilized alone or in combination with other medications for the treatment of cancer of the ovaries that has spread to other parts of the body, not improved, and worsened after treatment with other radiation or medications therapy. It belongs to a class of medications referred to as platinum-containing compounds. It works by inhibiting or slowing the growth of cancer cells.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Sanofi SA, among others.
A full Report of Global Carboplatin Injection Market is Available @ https://www.omrglobal.com/industry-reports/carboplatin-injection-market
Global Carboplatin Injection Market Report by Segment
By Product Type
- 10 ML :50MG
- 10 ML:100MG
By Application
- Breast Cancer
- Ovarian Cancer
- SCLC
- Others
Global Carboplatin Injection Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/carboplatin-injection-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
